ATE490346T1 - In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes - Google Patents

In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes

Info

Publication number
ATE490346T1
ATE490346T1 AT01975218T AT01975218T ATE490346T1 AT E490346 T1 ATE490346 T1 AT E490346T1 AT 01975218 T AT01975218 T AT 01975218T AT 01975218 T AT01975218 T AT 01975218T AT E490346 T1 ATE490346 T1 AT E490346T1
Authority
AT
Austria
Prior art keywords
vaccine
immunogenicity
test methods
vitro test
immunogenically
Prior art date
Application number
AT01975218T
Other languages
English (en)
Inventor
Mark Schenerman
Sheau-Chiann Wang
Robert Strouse
Joann Suzich
Wendy White
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Application granted granted Critical
Publication of ATE490346T1 publication Critical patent/ATE490346T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/084—Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT01975218T 2000-09-18 2001-09-17 In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes ATE490346T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23343900P 2000-09-18 2000-09-18
PCT/US2001/028877 WO2002024961A1 (en) 2000-09-18 2001-09-17 In vitro assay for measuring the immunogenicity of a vaccine

Publications (1)

Publication Number Publication Date
ATE490346T1 true ATE490346T1 (de) 2010-12-15

Family

ID=22877259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01975218T ATE490346T1 (de) 2000-09-18 2001-09-17 In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes

Country Status (9)

Country Link
US (1) US20020160358A1 (de)
EP (1) EP1319089B1 (de)
JP (1) JP4746819B2 (de)
AT (1) ATE490346T1 (de)
AU (1) AU2001294565A1 (de)
CA (1) CA2422635C (de)
DE (1) DE60143583D1 (de)
ES (1) ES2357381T3 (de)
WO (1) WO2002024961A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833724B2 (en) * 2006-03-20 2010-11-16 Teva Women's Health, Inc. Methods for comparing the immunogenicity of products and uses thereof
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
WO2008150276A2 (en) * 2006-09-26 2008-12-11 The Board Of Regents Of The University Of Texas System Virus coated nanoparticles and uses thereof
WO2015187158A1 (en) 2014-06-04 2015-12-10 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
WO2018226824A1 (en) * 2017-06-06 2018-12-13 Indevr, Inc. Simultaneous in vitro analysis of vaccine potency and toxin concentration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0422981A1 (de) * 1989-10-10 1991-04-17 Institut National De La Recherche Agronomique (Inra) Reagenzien und Verfahren zur immunochemischen Bestimmung des Denaturierungsgrads von proteinartigen Substanzen
ATE492289T1 (de) * 1993-03-09 2011-01-15 Univ Rochester Herstellung von menschlichen papillomavirus hbv- 11 kapsidprotein l1 und virus-ähnliche partikeln
US5654419A (en) * 1994-02-01 1997-08-05 The Regents Of The University Of California Fluorescent labels and their use in separations
EP1015561B1 (de) * 1997-09-05 2006-07-19 Medimmune, Inc. Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus-ähnlichen tielchen (vlps)

Also Published As

Publication number Publication date
JP2004510144A (ja) 2004-04-02
EP1319089B1 (de) 2010-12-01
EP1319089A4 (de) 2004-07-14
CA2422635C (en) 2011-11-15
ES2357381T3 (es) 2011-04-25
AU2001294565A1 (en) 2002-04-02
EP1319089A1 (de) 2003-06-18
DE60143583D1 (de) 2011-01-13
JP4746819B2 (ja) 2011-08-10
WO2002024961A1 (en) 2002-03-28
US20020160358A1 (en) 2002-10-31
CA2422635A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
CR20150350A (es) Proceso para preparar conjugados de anticuerpo y maytansinoide
DE60137663D1 (de) Elektrochemischer Sensor zur Bestimmung eines Analyts in Anwesenheit eines Störgases
TW200512457A (en) Method of diagnosing SARS corona virus infection
NO20004413L (no) HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en metode til å påvise antistoffer indusert av HIV
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
DE60228557D1 (de) Candida-nachweis
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
BRPI0518994A2 (pt) anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
FI20030921L (fi) Monikanavainen testiväline, menetelmä sen valmistamiseksi ja sen käyttö
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE299589T1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
ATE490346T1 (de) In vitro testverfahren zur bestimmung der immunogenizität eines impfstoffes
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
DE602004015953D1 (de) Festphase immunochromatographische testverfahren
WO2006093797A3 (en) Method and kit for detecting porcine reproductive and respiratory syndrome virus
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
CA2419046A1 (en) Method for detecting or measuring hbv
DE60025022D1 (de) Nachweis von hla-g
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties